CRISPR

-$1.70 (-1.72%) Today
+$0.70 (+0.72%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRISPR and other ETFs, options, and stocks.

About CRSP

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA.

CEO
Samarth Kulkarni
Employees
410
Headquarters
Zug, Zug
Founded
2014

CRSP Key Statistics

Market Cap
7.39B
Price-Earnings Ratio
18.99
Dividend Yield
—
Average Volume
2.32M
High Today
$99.81
Low Today
$96.65
Open Price
$99.23
Volume
1.85M
52 Week High
$220.20
52 Week Low
$84.38

CRSP News

BenzingaOct 13

Why CRISPR Therapeutics Stock Is Tumbling Today

CRISPR Therapeutics AG (NASDAQ: CRSP) is trading lower Wednesday after the company reported results from its Phase 1 CARBON trial of CTX110 in relapsed or refra
MarketWatchOct 13

Crispr's stock is down 5% after sharing early-stage data for its CAR-T therapy candidate

Shares of Crispr Therapeutics Inc. CRSP, +1.93% were down 5.8% in premarket trading on Wednesday, the day after the company announced data from a Phase 1 clinic

CRSP Earnings

-$1.51
$2.14
$5.79
$9.44
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure